Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK

Georgia Hollier-Hann; Alistair Curry; Kateryna Onishchenko; Ron Akehurst; Fayyaz Ahmed; Brendan Davies; Ian Keyzor

doi:10.1080/13696998.2019.1675417

Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK

Journal of Medical Economics ◽

10.1080/13696998.2019.1675417 ◽

2019 ◽

Vol 23 (1) ◽

pp. 113-123 ◽

Cited By ~ 2

Author(s):

Georgia Hollier-Hann ◽

Alistair Curry ◽

Kateryna Onishchenko ◽

Ron Akehurst ◽

Fayyaz Ahmed ◽

...

Keyword(s):

Cost Effectiveness ◽

Chronic Migraine ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

The Uk

Download Full-text

PND33 A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting

Value in Health ◽

10.1016/j.jval.2021.04.817 ◽

2021 ◽

Vol 24 ◽

pp. S164-S165

Author(s):

G. Weston ◽

A. Pinsent ◽

E. Adams ◽

W. Linley ◽

N. Hawkins ◽

...

Keyword(s):

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Dravet Syndrome ◽

Effectiveness Analysis ◽

The Uk

Download Full-text

Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial

HIV Medicine ◽

10.1111/hiv.12349 ◽

2015 ◽

Vol 17 (7) ◽

pp. 505-515 ◽

Cited By ~ 5

Author(s):

E Wilkins ◽

M Fisher ◽

AJ Brogan ◽

SE Talbird ◽

EM La

Keyword(s):

Clinical Trial ◽

Clinical Trials ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve ◽

Aids Clinical Trials ◽

The Uk ◽

Hiv 1

Download Full-text

PGI8 COST-EFFECTIVENESS ANALYSIS OF ROTAVIRUS VACCINATION PROGRAMME IN THE UK

Value in Health ◽

10.1016/s1098-3015(10)63332-3 ◽

2006 ◽

Vol 9 (6) ◽

pp. A243-A244 ◽

Cited By ~ 2

Author(s):

N Largeron ◽

M Trichard ◽

H Miadi-Fargier ◽

A Trancard ◽

A D'Ausilio ◽

...

Keyword(s):

Cost Effectiveness ◽

Vaccination Programme ◽

Cost Effectiveness Analysis ◽

Rotavirus Vaccination ◽

Effectiveness Analysis ◽

The Uk

Download Full-text

Cost Effectiveness Analysis of Flash Glucose Monitoring for Type 2 Diabetes Patients Receiving Insulin Treatment In The Uk

Value in Health ◽

10.1016/j.jval.2014.08.730 ◽

2014 ◽

Vol 17 (7) ◽

pp. A351 ◽

Cited By ~ 1

Author(s):

H. Li ◽

S.P. Bilir ◽

P. Donga ◽

A. Samiian ◽

J. Munakata

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Treatment ◽

Glucose Monitoring ◽

Cost Effectiveness Analysis ◽

Flash Glucose Monitoring ◽

Effectiveness Analysis ◽

The Uk ◽

Diabetes Patients

Download Full-text

A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK

The European Journal of Health Economics ◽

10.1007/s10198-016-0864-4 ◽

2017 ◽

Vol 19 (1) ◽

pp. 21-35 ◽

Cited By ~ 5

Author(s):

Evelina A. Zimovetz ◽

Alain Joseph ◽

Rajeev Ayyagari ◽

Josephine A. Mauskopf

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cost Effectiveness ◽

Attention Deficit ◽

Cost Effectiveness Analysis ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder ◽

Effectiveness Analysis ◽

The Uk

Download Full-text

Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK

PharmacoEconomics - Open ◽

10.1007/s41669-020-00202-1 ◽

2020 ◽

Vol 4 (4) ◽

pp. 635-648 ◽

Cited By ~ 2

Author(s):

Bernd Schweikert ◽

Chiara Malmberg ◽

Örjan Åkerborg ◽

Gayathri Kumar ◽

Debby Nott ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Cost Effectiveness ◽

Biologic Therapy ◽

Cost Effectiveness Analysis ◽

Severe Psoriasis ◽

Effectiveness Analysis ◽

The Uk

Download Full-text

Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long-term cost-effectiveness analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.13318 ◽

2018 ◽

Vol 20 (8) ◽

pp. 1921-1927 ◽

Cited By ~ 3

Author(s):

Anthony H. Barnett ◽

Simon Arnoldini ◽

Barnaby Hunt ◽

Gowri Subramanian ◽

Christina Stentoft Hoxer

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

The Uk

Download Full-text

Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece

Clinical Drug Investigation ◽

10.1007/s40261-019-00827-z ◽

2019 ◽

Vol 39 (10) ◽

pp. 979-990 ◽

Cited By ~ 5

Author(s):

Theodoros V. Giannouchos ◽

Dimos-Dimitrios Mitsikostas ◽

Robert L. Ohsfeldt ◽

Athanassios Vozikis ◽

Paraskevi Koufopoulou

Keyword(s):

Cost Effectiveness ◽

Chronic Migraine ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Updated cost-effectiveness analysis of palivizumab (Synagis) for the prophylaxis of respiratory syncytial virus in infant populations in the UK

Journal of Medical Economics ◽

10.1080/13696998.2020.1836923 ◽

2020 ◽

pp. 1-13

Author(s):

Omendra Narayan ◽

Anthony Bentley ◽

Katie Mowbray ◽

Monika Hermansson ◽

Dominic Pivonka ◽

...

Keyword(s):

Respiratory Syncytial Virus ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Syncytial Virus ◽

The Uk

Download Full-text

OP75 NICE Hips: hip replacement interventions for osteoarthritis in the UK – a clinical and cost-effectiveness analysis

Journal of Epidemiology & Community Health ◽

10.1136/jech-2014-204726.77 ◽

2014 ◽

Vol 68 (Suppl 1) ◽

pp. A37.2-A38

Author(s):

A Clarke ◽

R Pulikottil-Jacob ◽

A Grove ◽

K Freeman ◽

H Mistry ◽

...

Keyword(s):

Cost Effectiveness ◽

Hip Replacement ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

The Uk

Download Full-text